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Abstract
Background: The diagnostic criteria for primary stabbing headache (PSH) in the 3rd beta edition of International
Classification of Headache Disorders (ICDH-3 beta) were recently revised. In the ICDH-3 beta, PSH is defined as
short-lasting head pain spontaneous occurring as a single stab or series of stabs without autonomic symptoms and
involving all head areas (i.e., not limited to the ophthalmic branch region of the trigeminal nerve). The aim of this
study was to investigate the validity of the ICHD-3 beta criteria for PSH in a clinic-based setting.
Methods: We prospectively collected data from patients with complaint of headache with stabbing pain without
apparent cause at an initial visit to a secondary-care hospital from March 2009 to March 2014. Patients were
followed up for 2 weeks to assess changes in clinical characteristics and secondary causes of pain.
Results: Data from 280 patients with headache with stabbing pain without apparent cause were collected, and 245
patients were followed up for 2 weeks. Secondary causes for stabbing headache were observed in 9 patients
(herpes zoster in 7 patients and Bell’s palsy in 2 patients) after 2 weeks. The remaining 236 patients fulfilled the
diagnostic criteria for PSH according to ICHD-3 beta. Only 22 patients met the diagnostic criteria for PSH according
to ICHD-2.
Conclusions: All patients with headache with stabbing pain without cranial autonomic symptoms fulfilled the
diagnostic criteria for PSH according to ICHD-3 beta at the initial visit. Secondary causes for headache with stabbing
pain were revealed in a small proportion (3.7 %) of patients after 2 weeks of follow-up.
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Background
Stabbing pain in the head that lasts a few seconds is a
common type of headache [1–4]. The second edition of
the International Classification of Headache Disorders
(ICHD-2) proposed diagnostic criteria for this type of
headache, which is known as primary stabbing headache
(PSH) (code 4.1). These criteria require that head pain
occurs exclusively or predominantly in the first division
of the trigeminal nerve without apparent cause [5]. Pre-
vious studies have shown, however, that PSH can occur
outside the trigeminal region, including in the extrace-
phalic regions. The third beta edition of the Inter-
national Classification of Headache Disorders (ICHD-3
beta), therefore, has revised the diagnostic criteria for
PSH (code 4.1) as head pain that occurs spontaneously
as a single stab or series of stabs without cranial auto-
nomic symptoms in all head regions [1–4, 6–12].
The diagnostic criteria for PSH according to ICHD-3
beta have not been validated yet. The purpose of this
study was 1) to test the validity of the diagnostic criteria
for PSH according to ICHD-3 beta; 2) to investigate the
clinical characteristics of PSH according to pain location,
* Correspondence: hksong0@hanmail.net
Minwoo Lee and Min Kyung Chu are the first authors of this article.
†Equal contributors
1Department of Neurology, Kangdong Sacred Heart Hospital, Hallym
University Medical Center, Seongan-ro 150, Gangdong-gu, Seoul 134-701,
South Korea
Full list of author information is available at the end of the article
© 2016 Lee et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Lee et al. The Journal of Headache and Pain  (2016) 17:21 
DOI 10.1186/s10194-016-0615-z
which represents a criterion that changed from ICHD-2
to ICHD-3 beta; and 3) to investigate the clinical charac-
teristics of secondary stabbing headache (SSH) at a




We consecutively recruited patients with short-duration
headache without apparent cause who visited the
Department of Neurology at Kangdong Sacred Heart
Hospital, a secondary-care hospital in Korea, from
March 2009 to March 2014. Exclusion criteria included
1) 19 years old or younger; 2) patients with possible
causes for stabbing headache; and 3) patients who re-
fused to participate the study. After 5 years of consecu-
tive recruitment, we analyzed data of structured
interview and medical records of all the subjects in ac-
cordance with the ICHD-3 beta diagnostic criteria of
PSH in the present study. This study was approved by
the Institutional Review Board of Kangdong Sacred
Heart Hospital. Written informed consent was obtained
from all participants.
Assessment
A physician (HKS) interviewed all patients using a struc-
tured questionnaire and performed the physical examin-
ation. The information collected included age; gender;
headache duration; location, intensity, frequency, and
quality of pain; preceding infection; presence of allody-
nia; associated symptoms; and recurrence of stabbing
headache. Patients were followed up for 2 weeks to in-
vestigate response to treatment, change in clinical char-
acteristics, and secondary causes for stabbing headache.
The location of pain was recorded relative to the tri-
geminal and upper cervical regions. The trigeminal re-
gion was subdivided into ophthalmic (V1), maxillary
(V2), and mandibular (V3) branches. The upper cervical
region was subdivided into the lesser occipital nerve
(LON), greater occipital nerve (GON), and greater aur-
icular nerve.
A headache specialist (HKS) treated all patients with
PSH. Patients with PSH were treated with gabapentin
(300 mg bid), naproxen (275 mg bid), or amitriptyline
(5 mg hs) based on the judgement of the specialist. Each
patient was categorized as either a responder (cessation
of stabbing pain) or non-responder (continuation of
stabbing pain) in response to treatment after 2 weeks.
After 2 weeks of follow up, we asked our participants to
inform us if stabbing headache persisted more than
1 week or occurring other secondary causes of stabbing
headache to detect persisting symptoms or late-onset
SSH.
Statistics
Data were analyzed using SPSS Statistics for Windows,
Version 21 (Armonk, New York, USA). Student’s t-tests,
chi-square tests, and Mann–Whitney U tests were used




During the study period, a total of 280 patients with
stabbing headache were recruited during the initial visit.
Of these patients, 243 were prescribed medication for
their stabbing headache at the initial visit and 245 were
followed for 2 weeks (Fig. 1) Clinical characteristics at
initial visit.
Of the 280 patients with stabbing headache without
apparent cause at the initial visit, 103 were men and 177
were women. The mean age of patients was 51.4 ±
13.3 years. The mean duration from the onset of symp-
toms to the initial visit was 4.0 ± 3.7 days. The mean
visual analog scale (VAS) score for headache intensity
was 4.6 ± 1.6. Seventy-four (26.4 %) patients reported
mild pain (VAS score 1–3), 165 (58.9 %) reported mod-
erate pain (VAS score 4–6), and 41 (14.6 %) reported
severe pain (VAS score 7–10). The duration of a single
stab was within 1–2 s in 262 patients (93.6 %) and 3–5 s
in 18 patients (6.4 %). No patient reported autonomic
symptoms during their headache attacks. There was no
predominant pain lateralization (145 on the left, 133 on
the right, and 2 on both the left and right). Pain was re-
ported in the LON region in 129 patients, GON region
in 80 patients, V1 region of the trigeminal nerve in 27
patients, V2 region in 28 patients, and V3 region in 8 pa-
tients. One patient had pain in both the LON and GON,
and another patient had pain in both V1 and V2. No pa-
tients reported stabbing headache in both the trigeminal
and upper cervical regions. A total of 243 patients
Patients reporting 













Fig. 1 Flow chart of the number of participants at each stage of
the study
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(86.8 %) were treated with medication. Fifty-three pa-
tients (18.9 %) reported allodynia on the same side of
the stabbing headache. Allodynia was reported in 8
patients who reported stabbing headache in the V1
region (Table 1).
Clinical characteristics at follow-up
Of the 245 patients who were followed for 2 weeks after
the initial visit, 231 (94.3 %) reported improvements.
Mean duration for improvement among the responder
group was 3.2 ± 1.9 days. Secondary causes for stabbing
headache were observed in 9 patients (3.8 %) (herpes
zoster in 7 patients and Bell’s palsy in 2 patients); these
patients were initially diagnosed with PSH (Table 1). Im-
provement at follow-up was not significantly different
between those who did and did not take medication
(189/199 vs. 37/37, respectively; p = 0.164). Among 10
PSH patients with persisting stabbing headache at
follow-up, no patient additionally visited for their head-
aches. All 4 SSH patients with persisting stabbing head-
ache at follow-up were diagnosed as having herpes
zoster. Three of them improved their stabbing headache
after 1 week and the remaining 1 patient improved after
2 weeks.
Validating the ICHD-3 beta criteria for PSH
All 280 patients who participated in the present study
fulfilled the diagnostic criteria for PSH at the initial visit.
Of the 245 patients who were followed for 2 weeks, 9
(3.2 %) did not meet the criteria for PSH at the second
visit due to secondary causes for their stabbing head-
aches. These patients were diagnosed with SSH. Thus, at
follow-up, 236 patients were diagnosed with PSH ac-
cording to ICHD-3 beta. In contrast, only 28 patients
(10.0 %) fulfilled the ICHD-2 criteria for PSH (Fig. 2).
The remaining 252 patients were diagnosed with









Male 103 (36.8 %) 89 (37.7 %) 5 (55.5 %) 0.280
Female 177 (63.2 %) 147 (62.3 %) 4 (44.4 %)
Mean age 51.4 ± 13.3 50.6 ± 13.4 54.6 ± 14.1 0.385
Fixed location 230 (97.5 %) 9 (100 %) 0.628
Pain lateralization
Unilateral 278 (99.3 %) 234 (99.2 %) 9 (100.0 %) 0.781
Bilateral 2 (0.7 %) 2 (0.8 %) 0 (0.0 %)
Location of pain
V1 region 27 (9.6 %) 22 (9.3 %) 1 (11.1 %) 0.857
V2 region 28 (10.0 %) 27 (11.4 %) 1 (11.1 %)
V3 region 8 (2.9 %) 7 (3.0 %) 0 (0.0 %)
All trigeminal regions 63 (22.5 %) 55 (23.3 %) 2 (22.2 %) 0.940
Lesser occipital nerve region 129 (46.1 %) 109 (46.2 %) 4 (44.4 %)
Greater occipital nerve region 80 (28.6 %) 64 (27.1 %) 3 (33.3 %)
Great auricular nerve 6 (2.1 %) 6 (2.5 %) 0 (0.0 %)
All upper cervical regions 217 (77.5 %) 181 (76.7 %) 7 (77.8 %) 0.891
Multiple locations 2 (0.7 %) 2 (0.8 %) 0 (0.0 %) 0.782
Visual Analog Scale for pain intensity 4.6 ± 1.6 4.5 ± 1.6 6.8 ± 1.6 <0.001
Onset to hospital visit interval (days) 4.0 ± 3.7 4.0 ± 3.9 5.1 ± 2.4 0.341
Improvement at follow-up visit 226 (95.8 %) 5 (55.5 %) <0.001
Duration of improvement (days) among responders 3.2 ± 1.9 4.8 ± 1.5 0.060
Preceding infection 21 (7.5 %) 21 (8.9 %) 0 (0.0 %) 0.083
Stressful event 61 (21.8 %) 48 (20.3 %) 4 (7.7 %) 0.083
Allodynia 53 (18.9 %) 45 (19.1 %) 2 (22.1 %) 0.814
aAssessed at initial visit
bAssessed at follow-up visit
ICHD-3 beta: the third beta edition of the International Classification of Headache Disorders. V1: ophthalmic branch of trigeminal nerve; V2: maxillary branch of
trigeminal nerve; V3 mandibular branch of trigeminal nerve
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trigeminal neuralgia (N = 7, 2.5 %) or unclassified
headache (N = 245, 87.5 %) based on ICHD-2 criteria.
One patient (4.5 %) who was initially diagnosed with
PSH according to ICHD-2 criteria was diagnosed with
SSH due to Bell’s palsy at follow-up. The proportion
of patients with PSH re-diagnosed with SSH at
follow-up was not significantly different between
ICHD-3 beta and ICHD-2 criteria (9/271 vs. 1/27, p
= 0.919). No patient was classified as having probable
stabbing headache (code 4.7.1) at initial and follow-up
visit. The number of patients with PSH re-diagnosed
with SSH at follow-up was not significantly different
between ICHD-3 and ICHD-2 criteria.
Clinical characteristics of PSH and SSH
We compared demographic and headache characteristics
between PSH and SSH. There was no significant differ-
ence in gender, age, location of pain, preceding infection,
or stressful events between patients with PSH and pa-
tients with SSH. VAS for pain was significantly higher in
patients with SSH than patients with PSH. Improvement
in pain at follow-up was more common in patients with
PSH than patients with SSH. The duration of im-
provement among responders was longer in SSH than
PSH (Table 1). However, further follow up of patients
with SSH revealed favorable outcome within one
month of onset.
Clinical characteristics of PSH involving V1 compared with
other regions
Demographic and headache characteristics such as age,
gender, VAS for pain, improvement after 2 weeks, dur-
ation of improvement among responders, preceding
infection, stressful events, and allodynia were not
significantly different between patients with PSH who
reported V1 region involvement and those who reported
involvement of regions other than V1 except stressful
event history. Stressful event history was more common
among subjects with PSH involving other than V1
region (Table 2).
Clinical characteristics of PSH involving trigeminal area
and cervical area
We also compared clinical characteristics at initial visit
between PSH involving trigeminal area and cervical area.
Stressful event history was significantly higher among
PSH subjects involving cervical area than those involving
trigeminal area (Table 3).
Discussion
The key findings in the present study are as follows:
1) the diagnostic criteria for PSH in ICHD-3 beta
enabled diagnosis of primary headaches with stabbing
pain as PSH, most of which were not classified ac-
cording to ICDH-2 criteria; 2) a small proportion
(2.8 %) of new-onset stabbing headaches, which were
initially diagnosed as PSH, had secondary causes that
were revealed at 2-week follow-up; 3) pain intensity
was more severe and pain improvement was slower
among patients with SSH than that in patients with
PSH.
This is the first study to field test the ICHD-3 beta
diagnostic criteria for PSH. In the present study, all 280
subjects with short-lasting stabbing headache without
apparent cause and without autonomic symptoms at the
initial visit fulfilled the diagnostic criteria for PSH ac-
cording to ICHD-3 beta. In contrast, only 9.6 % of pa-
tients met the criteria for PSH according to ICHD-2.
This finding suggests that most primary stabbing head-
aches without cranial autonomic symptoms fulfill the
diagnostic criteria for PHS.
One important change in the diagnostic criteria for
PSH in ICHD-3 beta from ICHD-2 was the definition of
pain location. The diagnostic criteria for PSH in ICHD-3
beta included all head regions, whereas criteria in
ICHD-2 included the V1 region only [12]. To investigate
the clinical characteristics of PSH according to pain lo-
cation, we compared patients with PSH involving the V1
region to patients with PSH involving non-V1 regions.
Age, gender, pain intensity, improvement of pain,
duration of improvement among responders, preceding
infection, stressful events, and allodynia were not signifi-
cantly different according to pain location. These find-
ings suggest that all clinical characteristics of PSH
except pain location are similar between ICHD-3 beta
and ICHD-2.
Another change in ICHD-3 beta criteria from ICHD-2
criteria was the definition of accompanying symptoms.
PSH according to 
ICHD-3 beta,
N=280
PSH according to ICHD-2, 
N=28
Fig. 2 Distribution of participants diagnosed with primary stabbing
headache at the initial visit according to ICHD-3 beta and ICHD-2
criteria. PSH: primary stabbing headache; ICHD-2: the second edition
of the international classification of headache disorders; ICHD-3 beta:
the third beta edition of the international classification of the
headache disorders
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Diagnostic criteria for PHS in ICHD-2 included as a cri-
terion that no accompanying symptoms were present
[5]. According to ICHD-2, PSH was excluded as a diag-
nosis if stabbing headache without apparent cause was
accompanied by symptoms such as nausea, vomiting,
photophobia, or phonophobia [1, 5]. In ICHD-3 beta,
this criterion was revised to a lack of “cranial autonomic
symptoms” [12]. However, we did not investigate accom-
panying symptoms except allodynia, and no patient
reported cranial autonomic symptoms in the present
study. This change in the definition of accompanying
symptoms in ICHD-3 beta may have excluded fewer
primary headaches with stabbing pain as PSH than
ICHD-2.
PSH has been considered responsive to indomethacin
[13–16]. Responsiveness to indomethacin was described
in the “Comments” of ICHD-1 and ICHD-2 [5, 17].
However, responsiveness to indomethacin was removed
from ICHD-3 beta [12]. In the present study, no patient
was treated with indomethacin, and most patients with
PSH improved at follow-up. Mean duration for improve-
ment was 3.2 days among responders. In addition, im-
provement at follow-up was not significantly different
between patients who did and did not take medication.
Table 2 Clinical characteristics of primary stabbing headache by ICHD-3 beta criteria at initial visit according to the pain location
between V1 and other than V1
V1 regiona
N = 28




Male 13 (46.4 %) 90 (35.7 %) 0.265
Female 15 (53.6 %) 162 (64.3 %)
Age 50.5 ± 13.4 51.5 ± 13.3 0.912
Visual analog scale for pain intensity 4.4 ± 1.3 4.7 ± 1.6 0.160
Improvement at follow-upc 22 (100.0 %) 204 (95.3 %) 0.301
Mean duration of improvement (days)
among responders
4.1 ± 3.1 3.5 ± 2.7 0.135
Preceding infection 4 (14.2 %) 17 (6.7 %) 0.151
Stressful event history 2 (7.1 %) 59 (23.4 %) 0.048
Allodynia 8 (28.5 %) 45 (17.8 %) 0.170
aOne patient had stabbing headache in both the V1 and V2 regions
bV2, V3, lesser occipital nerve, greater occipital nerve, great auricular nerve, and multiple dermatomes. One patient with multiple dermatomes, including V1,
were included
c22 out of 28 patients with pain at V1 region and 216 out of 252 patients with pain at other than V1 regions were followed at 2 weeks after initial
visit, respectively
ICHD-3 beta: the third beta edition of the International Classification of Headache Disorders. V1: ophthalmic branch of trigeminal nerve; V2: maxillary branch of
trigeminal nerve; V3 mandibular branch of trigeminal nerve
Table 3 Clinical characteristics of primary stabbing headache by ICHD-3 beta criteria at initial visit according to the pain location







Male 23 (41.8 %) 80 (35.5 %) 0.388
Female 32 (58.9 %) 145 (64.5 %)
Age 49.5 ± 13.4 51.8 ± 13.2 0.968
Visual analog scale for pain intensity 4.4 ± 1.6 4.7 ± 1.6 0.787
Improvement at follow-up 43 (97.8 %) 188 (97.9 %) 0.937
Mean duration of improvement (days) among respondersc 3.8 ± 3.2 3.4 ± 2.7 0.145
Preceding infection 5 (10.9 %) 16 (7.1 %) 0.617
Stressful event history 6 (6.8 %) 55 (24.4 %) 0.029
Allodynia 14 (25.4 %) 39 (17.3 %) 0.168
aV1, V2 and V3 dermatomes
bLesser occipital nerve, greater occipital nerve, great auricular nerve, and multiple dermatomes. One patient with multiple dermatomes, including V1 region,
were included
c44 out of 55 patients with pain at trigeminal area and 192 out of 225 patients with pain at cervical area were followed at 2 weeks after initial visit, respectively
ICHD-3 beta: the third beta edition of the International Classification of Headache Disorders
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These findings suggest that most patients with PSH have
a good prognosis; specific responsiveness to indometh-
acin was difficult to conclude.
Our study, which followed patients who were initially
diagnosed with PSH, revealed that a small but significant
proportion of patients were found to have SSH at
follow-up. Previous studies have reported secondary
causes for stabbing headache, including Bell’s palsy,
herpes zoster, cerebral infarction, transient ischemic at-
tack, post-infection, thalamic hemorrhage, autoimmune
diseases, pituitary tumor, Chiari Malformation Type 1,
C1-C2 subluxation, meningioma, and multiple sclerosis
[2, 6, 15, 18–24]. We compared clinical characteristics of
PSH and SSH and found no significant differences ex-
cept in pain intensity. This finding suggests that the risk
for SSH is higher for a PSH-diagnosed stabbing head-
ache with severe pain intensity. The risk for SSH was
not significantly different between ICHD-3 beta and
ICHD-2 criteria in the present study.
Bell’s palsy and herpes zoster have been reported as
common causes of secondary stabbing headache [6, 24].
Retroauricular stabbing pain in Bell’s palsy often pre-
sents 2–3 days before the onset of facial weakness
[25, 26]. Herpes zoster is usually accompanied by
short-lasting stabbing pain in the involved sites. Pain
in herpes zoster often presents 4–5 days before the pres-
entation of skin lesions [26]. Most stabbing headaches are
reported to be improved within 2 weeks [1, 2]. Given these
findings, we followed patients with PSH for 2 weeks.
However, stabbing headache persisted in some patients,
and some SSH may have been classified as PSH in the
present study.
Our study has several limitations. First, we did not
perform nerve block or examine tenderness in the oc-
cipital area to diagnosis occipital neuralgia (ON). Ac-
cording to ICHD-3 beta, ON pain is associated with
tenderness over the affected nerve branch or trigger
points at the emergence of the greater occipital nerve or
C2 distribution [12]. Temporary relief of the pain by
local anesthetic block is also required. ON in the GON
and LON areas may have been diagnosed as PSH in the
present study. Second, not all patients were treated, and
treatment medication was not the same across patients.
In the present study, a headache specialist decided which
treatment to administer to each patient based on his
judgement. The rate and duration of improvement was
similar between patients who did and did not receive
treatment. This finding is consistent with previous stud-
ies in which PSH is reported to be an easily treatable
headache disorder [1, 2]. Third, we did not investigate
prior history of migraine or other primary headache dis-
orders. Though rather speculative, previous studies re-
ported that 21 - 38 % of patients with primary stabbing
headache had history of migraine [2, 16].
The strengths of this study are its large sample size, 2-
week follow-up to investigate changes in clinical charac-
teristics and secondary causes, comparisons of diagnostic
criteria between ICHD-3 beta and ICHD-2, and head-
ache diagnosis by a headache specialist, which may avoid
inter-examiner bias. Future work will include a longer
duration of follow-up and exclusion of ON via an exam-
ination of tenderness and performance of a nerve block.
Conclusion
In summary, the diagnostic criteria for PSH according to
ICHD-3 beta are valid and enable the diagnosis of most
primary headaches with stabbing pain, which were not
classified according to ICDH-2. A small proportion of
participants with PSH according to ICHD-3 beta criteria
at the initial visit were re-diagnosed with SSH at 2-week
follow-up owing to secondary causes. This information
may provide a better understanding of PSH and it diag-
nostic criteria according to ICHD-3 beta.
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